Related Experiment Video
Updated: May 23, 2025
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Global Research on the Treatment of Cancer Patients During the COVID-19 Pandemic: Visualisation and Bibliometric
1Department of Pharmacy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Aims:
The COVID-19 threatened global health, especially for cancer patients. We conducted a bibliometric analysis of the Science Citation Index literature published from 2019 to 2023 on the treatment of cancer patients during the COVID-19 pandemic, and explored the research trends and public interest in this topic.
Materials And Methods:
A total of 4,941 articles in the Web of Science core collection on this topic were retrieved. The online analysis platforms of literature metrology were employed to do statistical analysis of the global annual volume of documents and citation frequency, perform cocitation analysis on authors, journals, and references, draw visual maps for countries or regions cooperation, institutional cooperation, author cooperation, and keyword cooccurrence, and then conduct keyword cluster analysis and keyword bursting.
Results:
A total of 298 authors from 103 institutions and 74 countries or regions carried out research in the field, and the number of publications reached a peak in 2022. The United States, China, and Italy were the countries with the highest number of publications. The institutions that published the most papers are universities and research institutions. Keyword analysis showed that the research mainly focused on risk factors, outcomes, mortality, and therapy of cancer patients caused by COVID-19. Breast cancer was the cluster with the widest research scope. In addition to COVID-19, the burst keywords mainly included vaccination, delays, identification, immune response, malignancy, immunogenicity, and efficacy.
Conclusion:
The research on the treatment of cancer patients during the COVID-19 has shifted from laboratory research to clinical research, and the focus has gradually shifted from exploring the mechanism to improving the therapeutic effect. Developing vaccines and exploring treatment options that are more suitable for use in cancer patients, and investigating the relevance of the cytokine storms seem to concur with research priorities postpandemic. In the future, strengthening cooperation among countries or regions, institutions, and authors will be crucial for future pandemics.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Cancer Survival Analysis
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...